Diluted earnings per share in the first quarter was $0.20, down from $0.61 in the prior year, while adjusted EBITDA including joint ventures was $123 million, down from $202 million.
Specifically in the quarter, sales increased 13% to $984 million, with volume up 11% and price mix up 2%. During the quarter, we amended our revolver to increase its capacity from $750 million to $1 billion and extended its maturity date to August 2026.
We continue to expect our sales growth in fiscal 2022 to be above our long-term target of low to mid-single digits.
With respect to earnings, we expect net income and adjusted EBITDA including joint ventures will continue to be pressured through fiscal 2022.
